Latest Anticoagulants Stories
- Committee votes 9 to 1 to recommend approval of once-daily SAVAYSA for the reduction in risk of stroke and systemic embolic events (SEE) in patients with non-valvular atrial fibrillation (NVAF) TOKYO,
The Firm is evaluating Xarelto lawsuits on behalf of individuals who experienced uncontrollable bleeding and other serious complications, allegedly due to their use of the blood thinner.
As Xarelto Bleeding Lawsuits Continue To Be Filed, New Study Shows Bleeding Events Could Still Occur In Patients Taking Anticoagulant Medications Columbus, OH
Defendant Xarelto manufacturers want several lawsuits dismissed from Pennsylvania state court, arguing that there is no connection with the state. Rockville
The Firm is evaluating Xarelto lawsuits on behalf of individuals who suffered life-threatening internal bleeding, stroke, deep vein thrombosis, pulmonary embolism, or other serious injuries allegedly
The results of a recently-concluded study purport to show that Xarelto (rivaroxaban) is as safe as warfarin for patients atrial fibrillation patients awaiting elective cardioversion, even though
BARCELONA, Spain, September 2, 2014 /PRNewswire/ -- -- GARFIELD-AF Registry presentations at ESC CONGRESS 2014 provide insight into treatment and outcomes of patients
Results presented during ESC Congress 2014 Clinical Trial Update Hot Line session BARCELONA, Spain, Sept.
X-VeRT Study Results Presented as a Hot Line Session at the ESC Congress 2014 and Published in European Heart Journal BARCELONA, Spain, Sept.
A study released August 1 highlights the challenges related to managing anticoagulant–associated intracerebral hemorrhage (AAICH). Washington, D.C.
- A small wooded valley; a dell.
- The protecting weather-shed built around the entrance to a house.
- The roofed-over space between the kitchen and the sleeping-quarters in a logging-camp, commonly used as a storeroom.